A Study of Toripalimab+ Pemetrexed Plus Carboplatin in Patients With EGFR-mutation Positive and T790M Negative After Progression on EGFR-TKI Treatment
Clinical trial NCT03513666 · COMPLETED
Trial details
- NCT number
- NCT03513666
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-09
- Primary completion
- 2022-08-12
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.